Litcius/Paper detail

Polatuzumab Vedotin: a New Target for B Cell Malignancies

Yun Young Choi, Catherine Diefenbach

2020Current Hematologic Malignancy Reports24 citationsDOI

Topics & Concepts

MedicineBrentuximab vedotinBendamustineChemoimmunotherapyOncologyRituximabInternal medicineFollicular lymphomaVenetoclaxRefractory (planetary science)LymphomaClinical trialRegimenLeukemiaChronic lymphocytic leukemiaHodgkin lymphomaPhysicsAstrobiologyLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchViral-associated cancers and disorders
Polatuzumab Vedotin: a New Target for B Cell Malignancies | Litcius